This is one of the entries accepted for adjudication for the 2026 KS Innovation Awards, sponsored by the Vattikuti Foundation. Posting here does not imply being a Finalist.
Here is the Abstract:
First Italian Experience with Edge Multiport Robotic Prostatectomy
Subtitle: Surgical Technique and Outcomes of the First Italian
Consecutive Series
Presenting Author: 1Gabriele Bignante, MD
Urology Resident, Department of Oncology, University of Turin, Italy
E-mail: gabriele.bignante@unito.it
Contributors: 1E. Checcucci, 1D. Amparore, 1A. La Gatta, 1M. Ortenzi, 1G. Volpi,
2S. De Cillis, 1P. Alessio, 1M. Sica, 1E. Cisero, 2C. Fiori, 1F. Porpiglia
1Department of Surgery National Oncology Institute of Candiolo (INOC) – IRCCS
Candiolo, Turin, Italy
2Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Italy
Purpose of the Study
This study aims to describe the standardization of the surgical technique and evaluate perioperative,
oncological, and early functional outcomes of the first consecutive Italian series of Robot-Assisted
Radical Prostatectomy performed with the Edge Multiport MP1000 platform. The safety of the
system and effectiveness of the technological transition in surgeons with established experience on
other robotic platforms were assessed.
Materials and Methods
Between January and March 2026, sixteen consecutive patients with prostate adenocarcinoma underwent Robot-Assisted Radical Prostatectomy at our institution. Surgical planning was enhanced by high-fidelity three-dimensional Digital Twin models derived from multiparametric Magnetic Resonance Imaging to guide nerve-sparing strategies. A standard transperitoneal multiport approach was adopted. Technical parameters, including preparation, docking, and console
times, intraoperative outcomes, blood loss, and histopathological findings were analyzed.
Results
The Edge Multiport MP1000 system received European CE Mark certification in January 2025. In 16 procedures, mean draping time was 5.6 minutes, docking time 4.7 minutes, and console time 88.9 minutes. Eleven procedures were performed without lymph node dissection, while five included extended pelvic lymph node dissection. No intraoperative complications occurred; estimated blood loss ranged from 100 to 300 mL. Mean hospital stay was 2.5 days. No Clavien-
Dindo grade ≥III complications were observed, with a 12.5% minor complication rate. One positive surgical margin was reported (6.2%). Immediate urinary continence was achieved in 56.2% of
patients and increased to 93.7% at one month.
Conclusions
The Edge Multiport MP1000 platform demonstrated safety, reliability, and rapid integration into RARP practice. Early perioperative, oncological, and functional outcomes were consistent with
established robotic platforms, supporting adoption in experienced robotic centers.